stockrowLexicon Pharmaceuticals, Inc. (LXRX) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Lexicon Pharmaceuticals, Inc. LXRX 1.81 −3.21%
- Syndax Pharmaceuticals, Inc. SNDX 9.63 +0.42%
Lexicon Pharmaceuticals, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Lexicon Pharmaceuticals, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($863.4M and $832.6M). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 159.5% against −45.6%. Syndax Pharmaceuticals, Inc. has the higher net margin (−72.4% vs −161.8%) and the higher return on invested capital (−83.4% vs −109.1%). Across the 17 metrics below, Syndax Pharmaceuticals, Inc. leads on 10 and Lexicon Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | LXRX | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.89% | 92.21% | 68.81% |
| Operating margin | (147.42%) | (61.72%) | 0.00% |
| Net margin | (161.80%) | (72.38%) | 0.00% |
| Free cash flow margin | (127.76%) | (61.36%) | 0.00% |
| Return on equity | (43.91%) | (426.43%) | (50.30%) |
| Return on assets | (27.84%) | (33.67%) | (45.47%) |
| Return on invested capital | (109.13%) | (83.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack